These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

70 related articles for article (PubMed ID: 4906671)

  • 1. [The inflammatory cellular reactivity in patients with multiple myeloma. In vivo studies].
    Magliulo E; Petrocini S; Fossati GC; Gorini S
    Riv Emoter Immunoematol; 1967; 14(5):277-84. PubMed ID: 4906671
    [No Abstract]   [Full Text] [Related]  

  • 2. MICA expressed by multiple myeloma and monoclonal gammopathy of undetermined significance plasma cells Costimulates pamidronate-activated gammadelta lymphocytes.
    Girlanda S; Fortis C; Belloni D; Ferrero E; Ticozzi P; Sciorati C; Tresoldi M; Vicari A; Spies T; Groh V; Caligaris-Cappio F; Ferrarini M
    Cancer Res; 2005 Aug; 65(16):7502-8. PubMed ID: 16103105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The absence of CD56 on malignant plasma cells in the cerebrospinal fluid is the hallmark of multiple myeloma involving central nervous system.
    Chang H; Bartlett ES; Patterson B; Chen CI; Yi QL
    Br J Haematol; 2005 May; 129(4):539-41. PubMed ID: 15877737
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunophenotypic characterization of plasma cells from monoclonal gammopathy of undetermined significance patients. Implications for the differential diagnosis between MGUS and multiple myeloma.
    Ocqueteau M; Orfao A; Almeida J; Bladé J; González M; García-Sanz R; López-Berges C; Moro MJ; Hernández J; Escribano L; Caballero D; Rozman M; San Miguel JF
    Am J Pathol; 1998 Jun; 152(6):1655-65. PubMed ID: 9626070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma.
    Lin P; Owens R; Tricot G; Wilson CS
    Am J Clin Pathol; 2004 Apr; 121(4):482-8. PubMed ID: 15080299
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multifocal neuropathy due to plasma cell infiltration of peripheral nerves in multiple myeloma.
    Denier C; Lozeron P; Adams D; Decaudin D; Isnard-Grivaux F; Lacroix C; Said G
    Neurology; 2006 Mar; 66(6):917-8. PubMed ID: 16567713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dysregulation of CD47 and the ligands thrombospondin 1 and 2 in multiple myeloma.
    Rendtlew Danielsen JM; Knudsen LM; Dahl IM; Lodahl M; Rasmussen T
    Br J Haematol; 2007 Sep; 138(6):756-60. PubMed ID: 17760807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dutcher-Fahey intranuclear inclusions in multiple myeloma.
    Ma ES; Shek TW
    Br J Haematol; 2005 Apr; 129(2):164. PubMed ID: 15813843
    [No Abstract]   [Full Text] [Related]  

  • 9. Ultrastructural and immunochemical characterizatiog of one case of IgD myeloma.
    Mazzei D; Sessa A; Ortolani C; Cattaneo R; Mignone V
    Prog Immunobiol Stand; 1970; 4():174-8. PubMed ID: 4991581
    [No Abstract]   [Full Text] [Related]  

  • 10. Patients with CD45 negative multiple myeloma receiving high-dose therapy have a shorter survival than those with CD45 positive multiple myeloma.
    Moreau P; Robillard N; Avet-Loiseau H; Pineau D; Morineau N; Milpied N; Harousseau JL; Bataille R
    Haematologica; 2004 May; 89(5):547-51. PubMed ID: 15136217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The local inflammatory response in leukocyte disorders.
    Bambara LM; Celebrano R; Corrocher R; De Sandre G
    Haematologica; 1979 Aug; 64(4):403-15. PubMed ID: 121576
    [No Abstract]   [Full Text] [Related]  

  • 12. Human myeloma cells express the CD38 ligand CD31.
    Vallario A; Chilosi M; Adami F; Montagna L; Deaglio S; Malavasi F; Caligaris-Cappio F
    Br J Haematol; 1999 May; 105(2):441-4. PubMed ID: 10233418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased expression of the high-affinity receptor for IgG (FcRI, CD64) on neutrophils in multiple myeloma.
    Ohsaka A; Saionji K; Takagi S; Igari J
    Hematopathol Mol Hematol; 1996; 10(3):151-60. PubMed ID: 8878733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The immunological phenotype and proliferative activity of the tumor lymphocytes in multiple myeloma].
    Golenkov AK; Nazarova IN; Sarycheva TG; Miterev GIu; Kozinets GI
    Ter Arkh; 1993; 65(7):38-41. PubMed ID: 8211777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [On set and course of myeloma].
    Brücher H
    Schweiz Med Wochenschr; 1970 Feb; 100(7):340-1. PubMed ID: 5413926
    [No Abstract]   [Full Text] [Related]  

  • 16. Bone marrow endothelial cells in multiple myeloma secrete CXC-chemokines that mediate interactions with plasma cells.
    Pellegrino A; Ria R; Di Pietro G; Cirulli T; Surico G; Pennisi A; Morabito F; Ribatti D; Vacca A
    Br J Haematol; 2005 Apr; 129(2):248-56. PubMed ID: 15813853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasmacytic infiltrates of the skin as the first clinical manifestation of multiple myeloma.
    Cholongitas E; Pipili C; Katsogridakis K; Zouli C; Rellos K; Dasenaki M; Kaklamanis L
    Int J Dermatol; 2007 Dec; 46(12):1323-4. PubMed ID: 18173542
    [No Abstract]   [Full Text] [Related]  

  • 18. Instability of immunophenotype in plasma cell myeloma.
    Cao W; Goolsby CL; Nelson BP; Singhal S; Mehta J; Peterson LC
    Am J Clin Pathol; 2008 Jun; 129(6):926-33. PubMed ID: 18480010
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Multiple myeloma plasma cells show different chemokine receptor profiles at sites of disease activity.
    Trentin L; Miorin M; Facco M; Baesso I; Carraro S; Cabrelle A; Maschio N; Bortoli M; Binotto G; Piazza F; Adami F; Zambello R; Agostini C; Semenzato G
    Br J Haematol; 2007 Sep; 138(5):594-602. PubMed ID: 17686053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Non-secretory myeloma of heavy mu-chain type].
    Leglise MC; Briere J; Abgrall JF; Hurez D
    Nouv Rev Fr Hematol (1978); 1983; 25(2):103-6. PubMed ID: 6408608
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.